ArticleTheranostics2019

A novel anti-DR5 antibody-drug conjugate possesses a high-potential therapeutic efficacy for leukemia and solid tumors.

Shuyong Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.